The Orphan Drug Act and the development of stem cell-based products for rare diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20804965.
- Also identified by DOI 10.1016/j.stem.2010.08.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many conditions that stand to benefit from stem cell-based products are rare diseases. We address the Orphan Drug Act in relation to the development of stem cell-based products.
Medical subject headings
- Rare Diseases
- Stem Cells